James Noble, Director at GW PHARMACEUTICALS PLC (GWPH), sold 82,596 shares at $15.17 ($1.3M) on 2019-05-24, disclosed to the SEC on 2019-05-29.
Open-market sale of $1.3M GWPH by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $15.17 | 13,200 | $200K | 15.8% |
| 2 | $15.26 | 41,796 | $638K | 50.4% |
| 3 | $15.32 | 10,200 | $156K | 12.4% |
| 4 | $15.49 | 3,600 | $56K | 4.4% |
| 5 | $15.58 | 13,800 | $215K | 17.0% |
| Total | $15.32 avg | 82,596 |
| $1.3M |
| 100% |
| Filing → |
| CRGN | BUY | 2007-05-09 | $57K | — | Filing → |